As the United States healthcare system moves to value-based care, there have been clear signs of progress when it comes to better aligning incentives, but affordability remains a hurdle that needs to be overcome, said Bernard J. Tyson, chairman and CEO of Kaiser Permanente.
As the United States healthcare system moves to value-based care, there have been clear signs of progress when it comes to better aligning incentives, but affordability remains a hurdle that needs to be overcome, said Bernard J. Tyson, chairman and CEO of Kaiser Permanente.
Transcript (slightly modified)
What has the US healthcare system gotten right in the move to value-based care?
I think they have gotten the whole notion of how do we better align the incentives of the entire healthcare system, and so I think that clearly that is showing signs of progress.
I would say the second thing is the incentives around focusing on health and looking at the wholistic person is clearly headed in the right direction.
And then, lastly I would say, we are beginning to focus much more on outcomes as opposed to process. And so, value-based care and value-based payments around that is starting to get us to talk in the industry much more about outcomes of care as opposed to just procedures, and I think those all are very good signs.
What remains the biggest hurdle facing the US healthcare system in the move to value-based care?
Clearly, it’s the affordability issue. The new payment programs are all headed in the right direction, but at the end of the day from all walks of life we hear people talking about how unaffordable healthcare is. So, that is still the major issue that we have to continue to solve.
During the transformation of the US healthcare system, what is the importance of creating valueable partnerships?
Well, the healthcare industry is still very fragmented. It’s siloed. You have pieces of the industry that still work within itself. The hospital part, the physician groups, the labs, and so what still needs to happen is how do we better integrate and look across the whole process of care and care delivery. And that is going to continue to require us to work together to figure out how to pull all the pieces together. And you know my view is in the future it will look more and more, quite frankly, like the Kaiser Permanente model in which all the pieces are brought together, and we are able to provide the longitudinal care because we cover all the pieces inside of Kaiser Permanente.
Dr Kathy Zackowski Discusses the Importance of Rehabilitation Research and Trials in MS
April 26th 2024Kathy Zackowski, PhD, National MS Society, expresses the inherent value of quality rehabilitation trials for broadening clinical understandings of multiple sclerosis (MS) and bettering patient outcomes.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Dr Michael Farwell on FDG PET/CT Imaging to Predict Immunotherapy Response in Advanced Melanoma
April 15th 2024Michael Farwell, MD, associate professor of radiology at the Hospital of the University of Pennsylvania, provides insights into a study on the benefits of using 18F-fluorodeoxyglucose (FDG) PET/CT imaging to detect metabolic tumor changes in skin cancer.
Read More